Share

    


In This Section

Home / Blurb / Discussion List

Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA

May 23, 2018, 11:49 AM
URL:
https://www.accc-cancer.org/docs/pdf/retacrit-fda-approval-press-release.pdf?sfvrsn=22f1d018_0

Leave a comment